Related Experiment Video

Updated: Feb 22, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

910

Patients with Intermediate Risk Prostate Cancer May be Good Candidates for Active Surveillance: Con

Jeffrey J Tosoian1, H Ballentine Carter1

  • 1James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

The Journal of Urology
|September 27, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.5K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.2K

Related Experiment Videos

Last Updated: Feb 22, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

910
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.5K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.2K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

793
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
793

Articles linked to this work by shared authors, journal, and citation graph.

Long-term oncological outcomes from a prospective cohort of patients with localised prostate cancer.

BJU international·2026

Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer.

Clinical genitourinary cancer·2026

Fully Wireless and Flexible Valves for Multiplexed and Prolonged Intravesical Liquid Release.

Advanced healthcare materials·2026

Noninvasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Multisite Validation and Comparison with MRI.

The Journal of urology·2026

Blood- and urine-based biomarkers for the detection of clinically significant prostate cancer: a contemporary review.

Current opinion in urology·2025

Integration and evaluation of implementation strategies to improve guideline-concordant bladder cancer surveillance: a prospective observational study.

Implementation science communications·2025

2026 Updates to the Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer: AUA/SUO Guideline.

The Journal of urology·2026

Factors and Reasons Influencing Compliance with Post-vasectomy Semen Analysis: A Systematic Review.

The Journal of urology·2026

Anastomotic Urethroplasty is Associated with a Lower Risk of Stricture Recurrence Compared to Buccal Mucosa Graft Onlay after Reconstruction for Radiation-Induced Bulbomembranous Urethral Stenosis.

The Journal of urology·2026

Non-Muscle Invasive Recurrence and Management During Surveillance in Patients with Muscle-Invasive Bladder Cancer Who Achieve Clinical Complete Response to Neoadjuvant Chemotherapy.

The Journal of urology·2026

TESTOSTERONE THERAPY IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER IS NOT ASSOCIATED WITH INCREASED RISK OF DISEASE PROGRESSION.

The Journal of urology·2026

An integrative clinical-molecular model as an auxiliary predictive tool for glioma malignancy grade.

Neurological research·2026

Evaluating adenoma detection and miss rates in tandem colonoscopy: Limitations of surrogate quality indicators.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University·2026

Predicting Radioiodine Therapy Response in Advanced and Recurrent Thyroid Cancer.

Endocrine-related cancer·2026

Effectiveness of Selective Cyclooxygenase-2 Inhibitors for Postoperative Pain Management Using Multidimensional Pain Assessment: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Anesthesiology·2026

Refining risk stratification after indeterminate urinary cytology: Evidence from Bladder EpiCheck.

Cancer cytopathology·2026

PGR expression as a pharmacogenomic companion biomarker to GENE70-derived genomic risk in ER-positive/HER2-negative breast cancer.

Pakistan journal of pharmaceutical sciences·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us